| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
52,775,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,247,701 |
Avg
Vol: |
599,363 |
| 52
Week Range: |
$10.49 - $10.49 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bal Bruce J |
Sr.VP, Operations |
• – – |
2009-08-17 |
4 |
D |
$1.85 |
$1,983 |
D/D |
(1,072) |
76,620 |
|
- |
|
| Griffith Joseph H. Iv |
VP, Finance & Controller |
• – – |
2009-07-01 |
4 |
D |
$1.67 |
$793 |
D/D |
(475) |
12,681 |
|
- |
|
| Billet Van |
Director |
– • – |
2009-06-04 |
4 |
OE |
$1.54 |
$7,857 |
D/D |
5,102 |
9,219 |
|
- |
|
| Milligan David V |
Director |
– • – |
2009-06-04 |
4 |
OE |
$1.54 |
$7,857 |
D/D |
5,102 |
9,219 |
|
- |
|
| Comstock Allan L |
Director |
– • – |
2009-06-04 |
4 |
OE |
$1.54 |
$7,857 |
D/D |
5,102 |
10,219 |
|
- |
|
| Bishop Robert C |
Director |
– • – |
2009-06-04 |
4 |
OE |
$1.54 |
$11,224 |
D/D |
7,288 |
11,405 |
|
- |
|
| Tunstall Kathryn |
Director |
– • – |
2009-06-04 |
4 |
OE |
$1.54 |
$7,857 |
D/D |
5,102 |
9,219 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2009-06-04 |
4 |
OE |
$1.54 |
$7,857 |
D/D |
5,102 |
121,309 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2009-04-06 |
4 |
OE |
$1.07 |
$9,363 |
D/D |
8,750 |
296,524 |
|
- |
|
| Bal Bruce J |
Sr.VP, Operations |
• – – |
2009-03-30 |
4 |
D |
$1.00 |
$1,234 |
D/D |
(1,234) |
74,317 |
|
- |
|
| Kruka William C. |
Sr VP Corporate Development |
• – – |
2009-03-30 |
4 |
D |
$1.00 |
$1,400 |
D/D |
(1,400) |
26,371 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2009-03-30 |
4 |
OE |
$1.00 |
$9,000 |
D/D |
9,000 |
287,774 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2009-03-30 |
4 |
D |
$1.00 |
$1,400 |
D/D |
(1,400) |
30,268 |
|
- |
|
| Mcaree Peter F |
Sr.VP and CFO |
• – – |
2009-03-30 |
4 |
D |
$1.00 |
$475 |
D/D |
(475) |
34,159 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2009-03-30 |
4 |
D |
$1.00 |
$949 |
D/D |
(949) |
475,449 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2009-03-06 |
4 |
D |
$1.14 |
$2,209 |
D/D |
(1,938) |
28,418 |
|
- |
|
| Bal Bruce J |
Sr.VP, Operations |
• – – |
2009-03-06 |
4 |
D |
$1.14 |
$1,947 |
D/D |
(1,708) |
87,301 |
|
- |
|
| Mcaree Peter F |
Sr.VP and CFO |
• – – |
2009-03-06 |
4 |
D |
$1.14 |
$1,839 |
D/D |
(1,613) |
48,384 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2009-03-06 |
4 |
OE |
$1.14 |
$11,400 |
D/D |
10,000 |
278,774 |
|
- |
|
| Kruka William C. |
Sr VP Corporate Development |
• – – |
2009-03-06 |
4 |
D |
$1.14 |
$2,209 |
D/D |
(1,938) |
24,521 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2009-03-06 |
4 |
D |
$1.14 |
$1,947 |
D/D |
(1,708) |
473,898 |
|
- |
|
| Kruka William C. |
Sr VP Corporate Development |
• – – |
2009-02-27 |
4 |
D |
$0.90 |
$1,454 |
D/D |
(1,615) |
21,959 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2009-02-27 |
4 |
D |
$0.90 |
$1,454 |
D/D |
(1,615) |
25,856 |
|
- |
|
| Bal Bruce J |
Sr.VP, Operations |
• – – |
2009-02-27 |
4 |
D |
$0.90 |
$1,282 |
D/D |
(1,424) |
84,509 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2009-02-27 |
4 |
D |
$0.90 |
$1,025 |
D/D |
(1,139) |
471,106 |
|
- |
|
291 Records found
|
|
Page 6 of 12 |
|
|
